The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.70
Bid: 23.00
Ask: 24.40
Change: 0.00 (0.00%)
Spread: 1.40 (6.087%)
Open: 23.70
High: 23.70
Low: 23.70
Prev. Close: 23.70
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Growth Share Scheme

28 Jun 2021 07:00

RNS Number : 2303D
Mission Group PLC (The)
28 June 2021
 

28 June 2021

The Mission Group plc

 

("MISSION" "The Company" or "The Group")

 

Growth Share Scheme

 

The Mission Group plc ("MISSION", "the Company" or "the Group", AIM: TMG), the alternative group for ambitious brands, announces the formation of a new senior management retention and incentive scheme.

 

The Growth Share Scheme Arrangement 2 (the "Scheme") has been designed to further increase cross-selling incentives between the MISSION agencies and focus on driving the Group forward and increasing shareholder value. The Scheme has been launched following the performance condition of the original Growth Share Scheme Arrangement 1, introduced in February 2017, being met in June 2019. It has been created to retain and incentivise those key people who the board believes will be crucial to the MISSION'S long-term ambitions, and only has value to the participants if the share price of the Company increases substantially.

 

The Scheme

Under the Scheme, individuals are invited to subscribe for B ordinary shares in The Mission Marketing Holdings Limited ("B Shares"). These B Shares are subscribed for at a nominal value of 0.01p per B Share and will only have a material value if at any time in the period ending on the date the Company's financial results for the year ended 31st December 2023 are announced, the closing market value of the Company equals or exceeds 150p per share for fifteen consecutive days when the AIM market is open for business ("Vesting Conditions"). If the Vesting Conditions are met, the individuals will be entitled to require the Company to acquire their B Shares for an equivalent number of Ordinary Shares of 10p each in the Capital of the Company ("Ordinary Shares"), for cash (calculated on the basis of a price per B Share equal to the market value of an Ordinary Share at that time) or for a combination of Ordinary Shares and cash, at the Company's discretion. The B Shares have no value if the Vesting Conditions are not met.

 

To achieve the Vesting Conditions, the share price of the Company will need to increase by 106.9% from its current level, representing an increase in market capitalisation of approximately £70m. Under the Scheme, the B Shares would have an aggregate value at this level of approximately £4.7m and could be exchanged for 3,100,000 Ordinary Shares. The total potential number of Ordinary Shares that could be issued under the Scheme and under other existing option schemes is 3,824,046, representing 4.2% of the issued share capital.

 

In total, 3,100,000 B Shares were subscribed for on 25 June 2021 (the "Award") by a limited number of board members and non-PDMR senior managers. The subscription details for board members of MISSION are detailed below.

 

Name

Position

B Shares

Dylan Bogg

Executive Director

72,727

James Clifton

Group Chief Executive

240,000

Julian Hanson-Smith

Non-Executive Director

100,000

Giles Lee

Group Chief Financial Officer

240,000

Sue Mullen

Executive Director

142,857

Andy Nash

Non-Executive Director

72,727

Fiona Shepherd

Executive Director

240,000

 

* The Vesting Conditions require the closing market value of the Company to equal or exceed 150p per share for fifteen consecutive days when the AIM market is open for business at any time prior to the date on which the Company's financial results for the year ended 31st December 2023 are announced.

 

 

Enquiries:  

James Clifton, Chief Executive

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

 

020 7462 1415

 

Mark Percy / James Thomas / Sarah Mather (Corporate Advisory)

Shore Capital (Nomad and Broker)

020 7408 4090

 

Kate Hoare / Laura Stewart

0204 529 0549

HOUSTON (Financial PR and Investor Relations)

 

 

MISSION is a collective of Creative and MarTech Agencies led by entrepreneurs who encourage an independent spirit. Employing 1,000 people across 27 locations and 3 continents, the Group successfully combines its diverse expertise to bring about commercially effective solutions for some of the world's biggest Clients. 

 www.themission.co.uk

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

 

Dylan Bogg

James Clifton

Julian Hanson-Smith

Giles Lee

Sue Mullen

Andy Nash

Fiona Shepherd

 

2

 

Reason for the notification

a)

 

Position/status

 

 

Dylan Bogg

 Executive Director

James Clifton

 Group Chief Executive

Julian Hanson-Smith

 Non-Executive Director

Giles Lee

 Chief Financial Officer

Sue Mullen

 Executive Director

Andy Nash

Non-Executive Director

Fiona Shepherd

 Executive Director

 

b)

 

Initial notification /Amendment

 

28 June 2021

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

The Mission Group plc

b)

 

LEI

213800L567CF3Z6GPZ03

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

B ordinary shares in The Mission Marketing Holdings Limited, exchangeable into ordinary shares of 10p each the capital of the Company upon the satisfaction of performance criteria 

 

GB00B11FD453

b)

 

Nature of the transaction

Award of Growth Shares  

c)

 

Price(s) and volume(s)

 

 

Price

Volume

Dylan Bogg

0.01p

72,727

James Clifton

0.01p

240,000

Julian Hanson-Smith

0.01p

100,000

Giles Lee

0.01p

240,000

Sue Mullen

0.01p

142,857

Andy Nash

0.01p

72,727

Fiona Shepherd

0.01p

240,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 1,108,311

 

0.01p

e)

 

Date of the transaction

25 June 2021

f)

 

Place of the transaction

Off Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRGDLXXDDGBU
Date   Source Headline
13th Jun 20227:00 amRNSEBT Share Dealing
10th Jun 20227:00 amRNSEBT Share Dealing
9th Jun 20227:00 amRNSEBT Share Dealing
1st Jun 20228:46 amRNSEBT Share Dealing
31st May 20227:00 amRNSEBT Share Dealing
24th May 202210:48 amRNSEBT Share Dealing
23rd May 20227:00 amRNSEBT Share Dealing
20th May 20227:00 amRNSEBT Share Dealing
19th May 20227:00 amRNSEBT Share Dealing
18th May 20227:00 amRNSEBT Share Dealing
17th May 20227:00 amRNSEBT Share Dealing
16th May 20227:00 amRNSEBT Share Dealing
12th May 20222:36 pmRNSEBT Share Dealing
20th Apr 20229:04 amRNSDirector Dealing
30th Mar 20227:00 amRNSDividend Timetable
29th Mar 20227:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
28th Feb 20227:00 amRNSACQUISITION OF LIVITY
19th Jan 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSDirector/PDMR Shareholding
10th Jan 20221:54 pmRNSHolding(s) in Company
5th Jan 202210:07 amRNSHolding(s) in Company
17th Dec 20217:00 amRNSDirectorate Change
29th Nov 202110:16 amRNSHolding(s) in Company
25th Oct 20214:49 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSAcquisition of Soul and Trading Update
24th Sep 20217:30 amRNSHolding(s) in Company
23rd Sep 20216:10 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSInterim Results for six months to 30 June 2021
14th Jul 20217:00 amRNSTRADING UPDATE AND NOTICE OF INTERIM RESULTS
28th Jun 20217:00 amRNSGrowth Share Scheme
25th Jun 20212:17 pmRNSHolding(s) in Company
15th Jun 20217:00 amRNSDirector/PDMR Shareholding
14th Jun 20211:38 pmRNSResult of AGM
14th Jun 20217:00 amRNSTR1: Notification of Major Holdings
11th May 20219:19 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirectorate Changes
26th Apr 20215:05 pmRNSCorrection: Director/PDMR Shareholding
26th Apr 202112:15 pmRNSDirector/PDMR Shareholding
19th Apr 20216:04 pmRNSDirector/PDMR Shareholding
14th Apr 20217:01 amRNSFinal Results for the Year Ended 31 December 2020
14th Apr 20217:00 amRNSChanges to the Board
11th Mar 20214:40 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSHolding(s) in Company
22nd Feb 20215:37 pmRNSDirector/PDMR Shareholding
9th Feb 20219:24 amRNSDirector/PDMR Shareholding
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSTrading Update and Notice of Results
11th Nov 20204:58 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.